CD1d–lipid-antigen recognition by the semi-invariant NKT T-cell receptor

The CD1 family is a large cluster of non-polymorphic, major histocompatibility complex (MHC) class-I-like molecules that bind distinct lipid-based antigens that are recognized by T cells. The most studied group of T cells that interact with lipid antigens are natural killer T (NKT) cells, which characteristically express a semi-invariant T-cell receptor (NKT TCR) that specifically recognizes the CD1 family member, CD1d. NKT-cell-mediated recognition of the CD1d–antigen complex has been implicated in microbial immunity, tumour immunity, autoimmunity and allergy. Here we describe the structure of a human NKT TCR in complex with CD1d bound to the potent NKT-cell agonist α-galactosylceramide, the archetypal CD1d-restricted glycolipid. In contrast to T-cell receptor–peptide-antigen–MHC complexes, the NKT TCR docked parallel to, and at the extreme end of the CD1d-binding cleft, which enables a lock-and-key type interaction with the lipid antigen. The structure provides a basis for the interaction between the highly conserved NKT TCR α-chain and the CD1d–antigen complex that is typified in innate immunity, and also indicates how variability of the NKT TCR β-chain can impact on recognition of other CD1d–antigen complexes. These findings provide direct insight into how a T-cell receptor recognizes a lipid-antigen-presenting molecule of the immune system.

[1]  S. Balk,et al.  Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain , 1993, The Journal of experimental medicine.

[2]  H. Iijima,et al.  Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to Vα14 NKT cells , 2001 .

[3]  R. Brutkiewicz,et al.  Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d‐specific ligands for NKT cells , 2005, European journal of immunology.

[4]  G. Besra,et al.  The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A Vagin,et al.  An approach to multi-copy search in molecular replacement. , 2000, Acta crystallographica. Section D, Biological crystallography.

[6]  A. Lanzavecchia,et al.  An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells , 1994, The Journal of experimental medicine.

[7]  K. Garcia,et al.  The Vα14 NKT Cell TCR Exhibits High-Affinity Binding to a Glycolipid/CD1d Complex1 , 2002, The Journal of Immunology.

[8]  David I. Stuart,et al.  Structure and binding kinetics of three different human CD1d–α-galactosylceramide–specific T cell receptors , 2006, The Journal of experimental medicine.

[9]  I. Wilson,et al.  Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria , 2006, Nature Immunology.

[10]  I. Wilson,et al.  Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor , 2005, Nature Immunology.

[11]  Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections , 2005, Nature.

[12]  Natalie A. Borg,et al.  A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition , 2006, The Journal of experimental medicine.

[13]  James McCluskey,et al.  A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. , 2003, Immunity.

[14]  Robyn L Stanfield,et al.  How TCRs bind MHCs, peptides, and coreceptors. , 2006, Annual review of immunology.

[15]  R. Proia,et al.  Lysosomal Glycosphingolipid Recognition by NKT Cells , 2004, Science.

[16]  Albert Bendelac,et al.  The biology of NKT cells. , 2007, Annual review of immunology.

[17]  R. Zinkernagel,et al.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.

[18]  M. Lafleur,et al.  Structural Features of the Acyl Chain Determine Self-phospholipid Antigen Recognition by a CD1d-restricted Invariant NKT (iNKT) Cell* , 2003, Journal of Biological Chemistry.

[19]  J. McCluskey,et al.  CD1d antigen presentation: treats for NKT cells , 2005, Nature Immunology.

[20]  Michael B Brenner,et al.  CD1: antigen presentation and T cell function. , 2004, Annual review of immunology.

[21]  Paul B. Savage,et al.  The Paradox of Immune Molecular Recognition of α-Galactosylceramide: Low Affinity, Low Specificity for CD1d, High Affinity for αβ TCRs1 , 2003, The Journal of Immunology.

[22]  V. Cerundolo,et al.  Vα24-JαQ-Independent, CD1d-Restricted Recognition of α-Galactosylceramide by Human CD4+ and CD8αβ+ T Lymphocytes1 , 2002, The Journal of Immunology.

[23]  L. Kaer,et al.  NKT cells: what's in a name? , 2004, Nature Reviews Immunology.

[24]  D. Ho,et al.  Recognition of bacterial glycosphingolipids by natural killer T cells , 2005, Nature.

[25]  H. Macdonald,et al.  Targeted Expression of Human CD1d in Transgenic Mice Reveals Independent Roles for Thymocytes and Thymic APCs in Positive and Negative Selection of Vα14i NKT Cells1 , 2005, The Journal of Immunology.

[26]  M. Kronenberg,et al.  Going both ways: immune regulation via CD1d-dependent NKT cells. , 2004, The Journal of clinical investigation.

[27]  I. Wilson,et al.  Structural requirements for antigen presentation by mouse CD1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  H. Macdonald,et al.  Cutting Edge: Influence of the TCR Vβ Domain on the Avidity of CD1d:α-Galactosylceramide Binding by Invariant Vα14 NKT Cells1 , 2003, The Journal of Immunology.

[29]  N. Segal,et al.  Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells , 2003, The Journal of experimental medicine.

[30]  J. Whisstock,et al.  A Structural Basis for the Selection of Dominant αβ T Cell Receptors in Antiviral Immunity , 2003 .

[31]  A. Vagin,et al.  Spherically averaged phased translation function and its applications to search of molecules and fragments in the macromolecular electron density maps , 2000 .

[32]  Natalie A Borg,et al.  T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I–bound peptide , 2005, Nature Immunology.

[33]  T. Yamamura,et al.  The Complementarity Determining Region 2 of BV8S2 (Vβ8.2) Contributes to Antigen Recognition by Rat Invariant NKT Cell TCR1 , 2006, The Journal of Immunology.

[34]  A. Fersht,et al.  The crystal structure of human CD1d with and without α-galactosylceramide , 2005, Nature Immunology.

[35]  Hiroshi Sato,et al.  Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors , 1997 .

[36]  鎌田 憲明.  Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to Vα14 NKT cells , 2001 .

[37]  S. Kaufmann,et al.  Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. McCluskey,et al.  Specificity on a knife-edge: the αβ T cell receptor , 2006 .

[39]  Nicholas A Williamson,et al.  A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule , 2007, Nature Immunology.